Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» SB-509
SB-509
Sangamo Nerve Regrowth Drug Fails Key Test
TheStreet.com
Mon, 10/3/11 - 10:40 am
nerve regrowth
Sangamo BioSciences
SB-509
diabetic neuropathy
Sangamo's Phase II Results To Be Announced Monday - Expect Good News
Seeking Alpha
Sun, 10/2/11 - 12:28 pm
Sangamo BioSciences
SB-509
diabetic neuropathy
Sangamo BioSciences to Host Conference Call to Discuss Results From Phase 2b Trial of SB-509 in Diabetic Neuropathy
Yahoo/PR NewsWire
Sat, 10/1/11 - 01:47 pm
Sangamo BioSciences
diabetic neuropathy
SB-509
The Wisdom Of The Crowds And Sangamo's Phase II B Clinical Trial Results
Seeking Alpha
Wed, 09/28/11 - 09:17 am
Sangamo BioSciences
SB-509
diabetic neuropathy
